U.S. Drug Spending Increases Most in 13 Years to $373.9 Billion - Bloomberg Business
Often times it seems that the news, particularly economic news is out of step with the price action in the stock market. This headline is not. No wonder healthcare is the best performing sector in…
Akorn, Inc $AKRX Catalysts are looming
Specialty pharmaceuticals, biotech, and even big cap pharma are exhibiting great relative price performance. One that we just purchased Monday, Akorn, Inc. (AKRX) on a sharp pullback based on…